Table 6.
Parameters | Gondar | Togo | Tanzania | Uganda | Eastern and southern Africa |
---|---|---|---|---|---|
Median (95% range) | Median (95% range) | Median (95% range) | Median (95% range) | Median (95% range) | |
WBC (×109/l) | 5.1 (3.2–8.8) | 4.1 (1.9–10.1) | 4.6 (3.0–7.9) | 4.9 (2.8–8.2) | 3.1–9.1 |
Neutrophils (Abs) | 2.7 (1.6–5.1) | 1.6 (0.5–5.4) | 2.2 (1.1–4.7) | NA | 1.0–5.3 |
Neutrophils (%) | 53 (36–69) | NA | 48.1 (32.0–69.1) | 38.9 (22.2–59.3) | 25–66 |
Lymphocyte (Abs) | 1.9 (1–3.5) | 2.1 (1.1–4.3) | 1.8 (1.1–3.0) | NA | 1.2–3.7 |
Lymphocyte (%) | 38 (22–55) | NA | 40.5 (20.8–56.7) | 44.4 (26.7–61.2) | 23–59 |
Mixed (Abs) | 0.5 (0.2–1) | NA | 0.5 (0.3–1.1) | NA | NA |
Mixed (%) | 9 (6–13) | NA | 10.3 (5.6–19.8) | NA | NA |
Platelet (×109/l) | 264 (128–432) | 239 (120–443) | 244 (150–398) | 218.5 (109–384) | 126–438 |
MCV (fl) | 92 (85–100) | 84.5 (80–99) | 89.4 (77.6–98.1) | 85 (71–97) | 68–98 |
RBC (×1012/l) | |||||
Male | 4.8 (3.45–6.25) 5.0 | 5.0 (3.3–6.4) | 5.21 (4.41–6.27) | 5.0 (3.8–6.1) | 4.0–6.4 |
Female | 1 (3.53–6.93) | 4.5 (3.1–6.0) | 4.69 (3.84–5.59) | 4.4 (3.3–5.3) | 3.8–5.6 |
Hgb (g/dl) | |||||
Male | 12.9 (11–16.7) | 15.8 (10.0–18.4) | 15.4 (13.7–17.7) | 14.5 (11.6–17.1) | 12.2–17.7 |
Female | 14.2 (11.5–18) | 13.0 (10.3–17.1) | 13.5 (11.1–15.7) | 12.8 (9.8–16.2) | 9.5–15.8 |
PCV (%) | |||||
Male | 45.2 (32.1–56.6) | 42.8 (28.0–54.0) | 46.6 (40.2–53.7) | 42.6 (33.8–49.5) | 35.0–50.8 |
Female | 46.9 (36.2–58.6) | 38.1 (28.0–47.0) | 41.5 (36.2–46.8) | 37.8 (28.3–46.8) | 29.4–45.4 |
MCH (pg) | |||||
Male | 28.6 (25.8–32.8) | 29.7 (26–36) | 30.0 (23.1–33.2) | 29.2 (23.0–33.8) | NA |
Female | 29 (26.6–33.3) | 29.3 (25–37) | 29.3 (24.2–33.1) | 29.5 (24.8–32.7) | NA |
MCHC (%) | |||||
Male | 30.8 (28.5–34.4) | 35.1 (29–39) | 33.3 (30.6–35.1) | 34.2 (32.4–35.3) | NA |
Female | 31.3 (29.5–34.4) | 35.1 (30–41) | 32.7 (30.4–34.8) | 34.2 (33.0–35.5) | NA |
RDW (%) | |||||
Male | 14 (12–17) | NA | NA | 12.8 (10.9–16.8) | NA |
Female | 14 (12–17) | NA | NA | 12.7 (11.0–17.3) | NA |
Abs absolute